Healthcare News and Research

Latest Healthcare News and Research

Report notes rise in obesity slowing, but still huge health, cost problem

The obesity rate may rise to 42 percent from about a third of the U.S. population by 2030 if nothing changes, according to a report. Preventing that increase may save about $550 billion in medical costs over the next 20 years, Eric Finkelstein, the study author and an associate research professor at Duke University, said during a press briefing.

9 May 2012

House GOP bill cuts Medicaid to protect military spending

The budget plan, developed by House Budget Committee Chairman Paul Ryan, R- Wis., targets a number of Obama administration domestic initiatives. It trims an estimated $261 billion in domestic spending over the next decade and undoes elements of the health law.

9 May 2012

Polls: Though numbers are tight, voters give Obama edge over Romney on Medicare, health care policies

Voters had more confidence in how GOP challenger Mitt Romney would handle the economy. Meanwhile, Rick Santorum, who previously had been a candidate in the Republican presidential primary, offered a late-night e-mail endorsement to Romney.

9 May 2012

Telit CC864-DUAL cellular module to connect next generation MCOT from CardioNet

Telit Wireless Solutions, a global leader in machine-to-machine (M2M) wireless technology, today announced its CC864-DUAL cellular module will connect the next generation Mobile Cardiac Outpatient Telemetry (MCOT) from CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias.

9 May 2012

IBN develops biochip for investigating the effect of drugs on cancer stem cells

Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells (CSCs). Published recently in Nano Today, this new technology could boost the development of more effective cancer drugs.

9 May 2012

Teva first quarter net revenues increase 25% to $5.1 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2012.

9 May 2012

Latest science reveals Australians need to swallow some grains of truth about staple foods

A new report has revealed that the simplification of complex nutritional messages has resulted in grain foods like bread and pasta becoming the ‘scapegoat’ for weight gain and bloating, despite ample research to the contrary.

9 May 2012

SurModics second quarter revenue declines 8% to $12.2 million

SurModics, Inc., a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced results for its fiscal 2012 second quarter.

9 May 2012

iBio receives U.S. patent for iBioModulator platform

iBio, Inc. today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator platform.

9 May 2012

Sheffield embryologist given prestigious honour by Health Secretary

Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer’s Healthcare Science event last week.

8 May 2012

Ads for “affordable care act” claim to protect Medicare: Really?

Proponents of the Patient Protection and Affordable Care Act have a very costly, tax-payer funded national advertising campaign--- posing as “protectors” of Medicare—even as the massively unpopular law cut $500-$800 billion from Medicare to fund expansion of Medicaid, shifting more medical care services to younger voters.

8 May 2012

Ritalin use in ADHD rises four-fold over a decade

According to latest figures prescriptions for Ritalin for attention deficit hyperactivity disorder (ADHD) have quadrupled in a decade. This has raised concerns that it is being given to children at the expense of alternative treatments and without appreciation of long-term effects.

8 May 2012

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer's Japanese subsidiary, Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd. entered into a co-promotion agreement for EYLEA aflibercept) Injection in Japan.

From Santen Pharmaceutical Co., Ltd. 8 May 2012

Covidien to unveil new OneShot renal denervation system at EuroPCR congress

Covidien, a leading global provider of healthcare products, will unveil its new OneShot renal denervation system at the EuroPCR congress in Paris, France, on May 16, 2012. Adding to the Company's broad and growing vascular therapies portfolio, the OneShot system is designed to treat patients with hypertension who are not responsive to traditional medical therapy.

8 May 2012

U.S. healthcare system could be burdened with 32 million more obese people within two decades

Researchers have forecast the cost savings and rise in obesity prevalence over the next two decades in a new public health study.

8 May 2012

First Edition: May 8, 2012

Today's headlines include highlights of how congressional action surrounding the budget and the student loan program could impact health policy.

8 May 2012

Mindray first quarter net revenues increase 21.1% to $219.0 million

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2012.

From Mindray 8 May 2012

Calif., Ore. and Mass. try new ways to control health costs

In Massachusetts, House lawmakers released their proposal to curb health care spending, by setting a goal.

8 May 2012

FDA approves Clinigen’s Foscavir sNDA to treat HIV/AIDS-related CMV infections and herpes

Clinigen Healthcare, the pharmaceutical products division of Clinigen Group, announced today that its supplemental new drug application (sNDA) for Foscavir (foscarnet sodium), a treatment for HIV/AIDS-related cytomegalovirus (CMV) infections and herpes, has been approved by the US Food and Drug Administration.

From Clinigen Group 8 May 2012

VOA News examines South Africa's rural public health sector

VOA News features a five-part series on South Africa's rural public health sector, which the news service writes is "plagued by a high burden of infectious diseases, severe doctor and nurse shortages, lack of medicines and essential medical equipment and incompetent management," resulting in high patient death rates.

8 May 2012